Sofinnova closes $375m fund

The San Francisco-based firm has raised its seventh fund, which will be used for pharmaceutical and IT investments in the US and in Europe.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this